Published in BMC Genomics on October 18, 2010
Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res (2012) 2.57
Heritability and genomics of gene expression in peripheral blood. Nat Genet (2014) 2.00
Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet (2015) 1.45
From sets to graphs: towards a realistic enrichment analysis of transcriptomic systems. Bioinformatics (2011) 1.15
Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations. Nucleic Acids Res (2013) 1.07
Empirical pathway analysis, without permutation. Biostatistics (2013) 1.00
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) (2013) 0.99
The limitations of simple gene set enrichment analysis assuming gene independence. Stat Methods Med Res (2012) 0.99
Centrality-based pathway enrichment: a systematic approach for finding significant pathways dominated by key genes. BMC Syst Biol (2012) 0.95
Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway. BMC Med Genomics (2011) 0.93
Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2. J Child Psychol Psychiatry (2015) 0.91
Gene set analysis approaches for RNA-seq data: performance evaluation and application guideline. Brief Bioinform (2015) 0.89
Gene set analysis for self-contained tests: complex null and specific alternative hypotheses. Bioinformatics (2012) 0.87
Pathprinting: An integrative approach to understand the functional basis of disease. Genome Med (2013) 0.86
PhysioSpace: relating gene expression experiments from heterogeneous sources using shared physiological processes. PLoS One (2013) 0.85
Redundancy control in pathway databases (ReCiPa): an application for improving gene-set enrichment analysis in Omics studies and "Big data" biology. OMICS (2013) 0.82
A statistical approach to selecting and confirming validation targets in -omics experiments. BMC Bioinformatics (2012) 0.81
Estimating differential expression from multiple indicators. Nucleic Acids Res (2014) 0.80
Uniform approximation is more appropriate for Wilcoxon Rank-Sum Test in gene set analysis. PLoS One (2012) 0.79
Multivariate inference of pathway activity in host immunity and response to therapeutics. Nucleic Acids Res (2014) 0.79
Integrative gene set analysis of multi-platform data with sample heterogeneity. Bioinformatics (2014) 0.78
PathwAX: a web server for network crosstalk based pathway annotation. Nucleic Acids Res (2016) 0.78
GO2MSIG, an automated GO based multi-species gene set generator for gene set enrichment analysis. BMC Bioinformatics (2014) 0.78
Gene set bagging for estimating the probability a statistically significant result will replicate. BMC Bioinformatics (2013) 0.77
Differential expression of transcription factors and inflammation-, ROS-, and cell death-related genes in organotypic cultures in the modiolus, the organ of Corti and the stria vascularis of newborn rats. Cell Mol Neurobiol (2014) 0.77
Toward a holistic view of transcriptional regulation. Circ Cardiovasc Genet (2011) 0.76
Principal components analysis and the reported low intrinsic dimensionality of gene expression microarray data. Sci Rep (2016) 0.75
Validation of MIMGO: a method to identify differentially expressed GO terms in a microarray dataset. BMC Res Notes (2012) 0.75
A strategy for evaluating pathway analysis methods. BMC Bioinformatics (2017) 0.75
A knowledge-based T2-statistic to perform pathway analysis for quantitative proteomic data. PLoS Comput Biol (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59
KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62
GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol (2003) 22.63
Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet (2006) 16.12
Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet (2007) 12.08
A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82
Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics (2007) 9.87
Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A (2005) 8.75
PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics (2005) 8.41
GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics (2007) 6.67
ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics (2005) 4.98
Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol (2006) 4.30
Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics (2005) 4.27
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest (2006) 3.95
A general modular framework for gene set enrichment analysis. BMC Bioinformatics (2009) 3.92
Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics (2007) 3.68
Correlation between gene expression levels and limitations of the empirical bayes methodology for finding differentially expressed genes. Stat Appl Genet Mol Biol (2005) 3.25
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01
Comparing functional annotation analyses with Catmap. BMC Bioinformatics (2004) 2.92
A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics (2006) 2.42
GlobalANCOVA: exploration and assessment of gene group effects. Bioinformatics (2007) 2.24
Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet (2007) 2.19
A new type of stochastic dependence revealed in gene expression data. Stat Appl Genet Mol Biol (2006) 2.15
Microarray-based gene set analysis: a comparison of current methods. BMC Bioinformatics (2008) 2.06
GEOmetadb: powerful alternative search engine for the Gene Expression Omnibus. Bioinformatics (2008) 1.68
Testing the additional predictive value of high-dimensional molecular data. BMC Bioinformatics (2010) 1.27
A biological evaluation of six gene set analysis methods for identification of differentially expressed pathways in microarray data. Cancer Inform (2008) 1.09
Re-sampling strategy to improve the estimation of number of null hypotheses in FDR control under strong correlation structures. BMC Bioinformatics (2007) 1.08
Gene set internal coherence in the context of functional profiling. BMC Genomics (2009) 1.04
Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery. Pharmacogenomics (2007) 0.83
Significance levels for studies with correlated test statistics. Biostatistics (2007) 0.82
Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol (2009) 22.22
Concordance among gene-expression-based predictors for breast cancer. N Engl J Med (2006) 13.50
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med (2005) 5.51
Theoretical and experimental comparisons of gene expression indexes for oligonucleotide arrays. Bioinformatics (2002) 4.85
Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics (2005) 4.27
ChIPOTle: a user-friendly tool for the analysis of ChIP-chip data. Genome Biol (2005) 3.83
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials (2002) 3.41
A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A (2010) 3.30
Retracted Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA (2008) 3.26
Integrated study of copy number states and genotype calls using high-density SNP arrays. Nucleic Acids Res (2009) 3.09
A powerful and flexible approach to the analysis of RNA sequence count data. Bioinformatics (2011) 2.49
Inferring missing genotypes in large SNP panels using fast nearest-neighbor searches over sliding windows. Bioinformatics (2007) 2.17
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet (2012) 2.14
Estimating odds ratios in genome scans: an approximate conditional likelihood approach. Am J Hum Genet (2008) 2.12
Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol (2005) 2.05
Merging two gene-expression studies via cross-platform normalization. Bioinformatics (2008) 1.93
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
Simulating association studies: a data-based resampling method for candidate regions or whole genome scans. Bioinformatics (2007) 1.77
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med (2015) 1.76
Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci (2006) 1.75
Genomic strategy for targeting therapy in castration-resistant prostate cancer. J Clin Oncol (2009) 1.75
seeQTL: a searchable database for human eQTLs. Bioinformatics (2011) 1.72
Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia. Nat Genet (2003) 1.71
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res (2009) 1.60
Epigenetic alterations in liver of C57BL/6J mice after short-term inhalational exposure to 1,3-butadiene. Environ Health Perspect (2010) 1.59
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet (2003) 1.59
Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest (2010) 1.59
Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol (2006) 1.53
Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am J Hum Genet (2003) 1.53
Public knowledge of and attitudes toward genetics and genetic testing. Genet Test Mol Biomarkers (2013) 1.52
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One (2013) 1.52
Retracted An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS One (2008) 1.45
Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy. Urology (2012) 1.43
Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral phenotype. Genetics (2006) 1.37
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study. Environ Health Perspect (2015) 1.37
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett (2012) 1.36
Rapid noninvasive optical imaging of tissue composition in breast tumor margins. Am J Surg (2009) 1.33
Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc Natl Acad Sci U S A (2002) 1.32
Use of in vitro HTS-derived concentration-response data as biological descriptors improves the accuracy of QSAR models of in vivo toxicity. Environ Health Perspect (2010) 1.31
Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis (2004) 1.31
CONVERGENCE AND PREDICTION OF PRINCIPAL COMPONENT SCORES IN HIGH-DIMENSIONAL SETTINGS. Ann Stat (2010) 1.31
Genome-level analysis of genetic regulation of liver gene expression networks. Hepatology (2007) 1.29
Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology (2005) 1.29
Sharing and Specificity of Co-expression Networks across 35 Human Tissues. PLoS Comput Biol (2015) 1.27
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol (2010) 1.27
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst (2010) 1.26
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet (2012) 1.26
FastMap: fast eQTL mapping in homozygous populations. Bioinformatics (2008) 1.25
JOINT AND INDIVIDUAL VARIATION EXPLAINED (JIVE) FOR INTEGRATED ANALYSIS OF MULTIPLE DATA TYPES. Ann Appl Stat (2013) 1.24
Quantification of population structure using correlated SNPs by shrinkage principal components. Hum Hered (2010) 1.24
Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol (2009) 1.23
Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol (2007) 1.20
Statistical challenges in preprocessing in microarray experiments in cancer. Clin Cancer Res (2008) 1.19
A Bayesian model for cross-study differential gene expression. J Am Stat Assoc (2009) 1.18
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. Cancer Invest (2010) 1.18
Use of cell viability assay data improves the prediction accuracy of conventional quantitative structure-activity relationship models of animal carcinogenicity. Environ Health Perspect (2008) 1.17
Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci (2006) 1.16
Practical FDR-based sample size calculations in microarray experiments. Bioinformatics (2005) 1.16
Standardizing benchmark dose calculations to improve science-based decisions in human health assessments. Environ Health Perspect (2014) 1.15
Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol (2008) 1.14
Assessing differential gene expression with small sample sizes in oligonucleotide arrays using a mean-variance model. Biometrics (2007) 1.14
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes (2010) 1.13
In vitro models for liver toxicity testing. Toxicol Res (Camb) (2012) 1.13
Sex differences in the human peripheral blood transcriptome. BMC Genomics (2014) 1.13
Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics (2008) 1.12
Quantitative high-throughput screening for chemical toxicity in a population-based in vitro model. Toxicol Sci (2012) 1.12
Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches. Chem Res Toxicol (2011) 1.11
Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel. Toxicol Sci (2009) 1.11
A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet (2002) 1.09
Comment on a simple and improved correction for population stratification. Am J Hum Genet (2008) 1.09
ToxPi GUI: an interactive visualization tool for transparent integration of data from diverse sources of evidence. Bioinformatics (2012) 1.09
The Set2/Rpd3S pathway suppresses cryptic transcription without regard to gene length or transcription frequency. PLoS One (2009) 1.09
Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity. Toxicol Appl Pharmacol (2013) 1.08
Indoor air pollutants and health in the United Arab Emirates. Environ Health Perspect (2012) 1.06
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis. Environ Health Perspect (2015) 1.05
Advancing optical imaging for breast margin assessment: an analysis of excisional time, cautery, and patent blue dye on underlying sources of contrast. PLoS One (2012) 1.04
Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol Sci (2007) 1.04
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Optical spectral surveillance of breast tissue landscapes for detection of residual disease in breast tumor margins. PLoS One (2013) 1.03
Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutat Res (2010) 1.03
Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet. Toxicol Appl Pharmacol (2012) 1.02
Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma. Mol Cancer (2010) 1.01
Integrative chemical-biological read-across approach for chemical hazard classification. Chem Res Toxicol (2013) 1.01
Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg (2016) 1.01
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. Gynecol Oncol (2011) 1.01
Empirical pathway analysis, without permutation. Biostatistics (2013) 1.00
Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2002) 1.00
In vitro screening for population variability in chemical toxicity. Toxicol Sci (2010) 1.00